1. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015) Authors: Colagrossi, L.; Salpini, R.; Surdo, M.; Battisti, A.; Pollicita, M.; Bertoli, A.; Di Santo, F.; Becker, C.; Mastroianni, C.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Sarmati, L.; Andreoni, M.; Angelico, M.; Verheyen, J.; Perno, C.F. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of T‐cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain‐like lesions during the COVID‐19 pandemic. (1st December 2021) Authors: Cassius, C.; Merandet, M.; Frumholtz, L.; Bergerat, D.; Samri, A.; Grolleau, C.; Grzelak, L.; Schwartz, O.; Yatim, N.; Moghadam, P.; Jaume, L.; Bagot, M.; Legoff, J.; Delaugerre, C.; Bouaziz, J.‐D.; Le Buanec, H. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of T‐cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain‐like lesions during the COVID‐19 pandemic. (7th September 2021) Authors: Cassius, C.; Merandet, M.; Frumholtz, L.; Bergerat, D.; Samri, A.; Grolleau, C.; Grzelak, L.; Schwartz, O.; Yatim, N.; Moghadam, P.; Jaume, L.; Bagot, M.; Legoff, J.; Delaugerre, C.; Bouaziz, J.‐D.; Le Buanec, H. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients. (3rd January 2015) Authors: Fourati, Slim; Charpentier, Charlotte; Amiel, Corinne; Morand-Joubert, Laurence; Reigadas, Sandrine; Trabaud, Mary-Anne; Delaugerre, Constance; Nicot, Florence; Rodallec, Audrey; Maillard, Anne; Mirand, Audrey; Jeulin, Hélène; Montès, Brigitte; Barin, Francis; Bettinger, Dominique; Le Guillou-Gui... Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 5(2015:May) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies. (26th February 2015) Authors: Frange, Pierre; Assoumou, Lambert; Descamps, Diane; Chéret, Antoine; Goujard, Cécile; Tran, Laurent; Gousset, Marine; Avettand-Fenoël, Veronique; Bocket, Laurence; Fafi-Kremer, Samira; Guinard, Jerome; Morand-Joubert, Laurence; Nicot, Florence; Plantier, Jean-Christophe; Rogez, Sylvie; Wirden, Ma... Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 7(2015:Jul.) Page Start: 2084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HIV‐1 drug resistance testing at second‐line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third‐line. Issue 10 (2nd October 2018) Authors: Fily, F.; Ayikobua, E.; Ssemwanga, D.; Nicholas, S.; Kaleebu, P.; Delaugerre, C.; Pasquier, E.; Amoros Quiles, I.; Balkan, S.; Schramm, B. Journal: Tropical medicine & international health Issue: Volume 23:Issue 10(2018) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016) Authors: Battisti, A.; Salpini, R.; Colagrossi, L.; Alteri, C.; Pollicita, M.; Ricciardi, A.; Cerva, C.; Maffongelli, G.; Lichtner, M.; Mastroianni, C.; Casinelli, K.; Paoloni, M.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Brega, A.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intensification with pegylated interferon during treatment with tenofovir in HIV–hepatitis B virus co‐infected patients. Issue 12 (3rd August 2016) Authors: Boyd, A.; Piroth, L.; Maylin, S.; Maynard‐Muet, M.; Lebossé, F.; Bouix, C.; Lascoux‐Combe, C.; Mahjoub, N.; Girard, P.‐M.; Delaugerre, C.; Carrat, F.; Lacombe, K.; Miailhes, P. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 12(2016) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands. (June 2020) Authors: Visseaux, B.; Hué, S.; Le Hingrat, Q.; Salmona, M.; Lebourgeois, S.; Delaugerre, C.; Descamps, D.; Chaix, M.-L.; Ghosn, J. Journal: Clinical microbiology and infection Issue: Volume 26:Number 6(2020) Page Start: 785.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?. (September 2016) Authors: Pialoux, G.; Delaugerre, C.; Cotte, L.; Raffi, F.; Cua, E.; Molina, J.-M. Journal: Clinical microbiology and infection Issue: Volume 22:Number 9(2016) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗